Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Reusable shopping bags encourage shoppers to buy produce -- and junk food?

  • Yes, it pays to win back lost customers

  • Can a humanlike figure actually harm a company?

  • Faced with limited choices, prisoners become entrepreneurs to meet their needs

  • Fewer women than men are shown online ads related to high-paying jobs

  • Adolescent exposure to e-cigarette tv ads increases likelihood of future use

  • Researchers learn to measure aging process in young adults

  • Brain imaging shows how children inherit their parents' anxiety

  • Life expectancy substantially lower with combination of diabetes, stroke or heart attack

  • Smartphones may be detrimental to learning process

  •